Skip to main content
. 2023 May 2;13:1180714. doi: 10.3389/fcimb.2023.1180714

Table 2.

Distribution of samples in light of antibiotic consumption in the 30 days prior to the collection of the rectal swab.

Antibiotic Consumption up to 30 Days Before Sample Collection
Patients With no Antibiotics Received 21
Patients that Received Antibiotics 69
Samples Collected with no Antibiotics Received 105
Samples Collected from Patients that Received Antibiotics 277
Number of Antibiotics Received (by Class) Number of Rectal Swabs
1 72
2 40
3 or more 165
Antibiotics Received Number of Rectal Swabs Median Days Received
Non-Carbapenem β-Lactams 217 3 (range: 1 – 38)
Glycopeptides 160 5 (range: 1 – 29)
Carbapenems 124 6 (range: 1 – 29)
Aminoglycosides 104 2 (range: 1 – 27)
Trimethoprim/Sulfamethoxazole 83 3 (range: 1 – 25)
Others 390 3 (range: 1 – 30)

1The other antibiotics received are macrolides, fluoroquinolones, linezolid, and the antifungals fluconazole, metronidazole, micafungin, and voriconazole.